Infections caused by gram-negative bacteria (GNB) resistant to multiple classes of antibiotics are increasing in many hospitals.
era, antimicrobial stewardship programs are essential as targeted and responsible use of antibiotics improves patient outcomes and hopefully limits the selective pressure that drives the further emergence of resistance.
However, some stewardship strategies aimed at promoting carbapenem-sparing regimens remain controversial and are difficult to implement when resistance rates to non-carbapenem antibiotics are increasing.
Coordinated efforts between stewardship programs and infection control are essential for reversing conditions that favor the emergence and dissemination of multidrug-resistant GNB within the hospital and identifying extra-institutional ''feeder reservoirs'' of resistant strains such as long-term care facilities, where colonization is common despite limited numbers of serious infections. In settings where ESBL resistance is endemic, the cost-effectiveness of expanded infection control efforts and antimicrobial stewardship is still unknown. Once a patient has been colonized, selective oral or digestive decontamination may be considered, but evidence supporting its effectiveness is limited in patients who are already colonized or in centers with high rates of resistance. Moreover, temporary success at decolonization may be associated with a higher risk of relapse with strains that are resistant to the decolonizing antibiotics.
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INTRODUCTION
Treating infections caused by gram-negative bacteria (GNB) resistant to multiple classes of antibiotics is an increasing challenge in many hospitals. Extended-spectrum b-lactamase (ESBL)-producing and carbapenem-resistant Enterobacteriaceae (CRE) in particular are now endemic in many parts of the world and represent one of the most serious public health threats [1, 2] . In this context, antimicrobial stewardship (AMS) programs play a critical role in improving appropriate antibiotic use to improve patient outcomes and reduce the antibiotic selective pressure that drives the emergence of further resistance. However, both the efficacy and collateral impact of many stewardship strategies are not well documented, starting from the battle against the overuse of carbapenems in non-critically ill patients to the use of carbapenem-sparing regimens also in critically ill patients in institutions with endemically high levels ([20%) of ESBL-producing Enterobacteriaceae.
Herein, we discuss the leading
stewardship-related controversies and infection control (IC) measures needed to control infections caused by ESBL-and CR-producing
Enterobacteriaceae. We also discuss recent efforts from our large teaching hospital to contain carbapenem resistance and its impact on other ESBL resistance rates. This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
ESBL-PRODUCING ENTEROBACTERIACEAE
ESBL-producing GNBs are now a universal health concern [2] . ESBL production is frequently accompanied by other resistance mechanisms that impart cross-resistance to many other anti-GNB antibiotics, including aminoglycosides and fluoroquinolones. Consequently, carbapenems have long been 
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
Over the last decade, the prevalence of infections with CRE has increased worldwide [1] , and given the limited therapeutic options for these infections, they are associated with high morbidity and mortality. The impact of carbapenem-sparing regimens on the outcome of CRE has only been investigated in a few small cohort studies. 
RAPID DIAGNOSTIC TESTS USED BY AMS PROGRAMS

INFECTION CONTROL CHALLENGES
In consideration of the steady increase of occurrence of infections caused by ESBL and carbapenemase-producing GNB, AMS programs have been incorporated into IC strategies designed to prevent the spread of MDR GNB. hands appeared to be low [70] .
Several studies showed a possible spread of ESBL-and/or AmpC-producing bacterial strains transmitted via the food chain or food animal production environment [71] [72] [73] . In this situation, it is reasonable to assume that a significant proportion of hospitalized patients may be colonized without detection before admission to the hospital and therefore are not assigned to isolation precautions. Further studies are needed to assess the cost effectiveness of a massive implementation of IC measures to contain the diffusion of ESBLs in endemic settings.
A clearer understanding of essential IC strategies has been described for limiting the spread of CRE. In a seminal study describing the containment of a country-wide outbreak of carbapenem-resistant K. pneumoniae in Israeli hospitals, Schwaber and colleagues [74] analyzed the impact of guidelines instituted by the (Fig. 1) . Our analysis showed this reduction was not coincidental, as CRE-screening compliance rates were associated with the observed reduction in the incidence of CRE carriage in the hospitalized population, as detected by monthly rectal swab cultures.
Moreover, when average compliance rates with the screening protocols waned after 20 months of the program (Fig. 1b) , rates of CRE BSI and positive-rectal swabs rebounded and only decreased once average screening compliance rates had been restored above 75% [76] .
Support of the regional health authority [77] and our hospital administration as well as the strict application of the IC policy were key elements in the success of the program and the AMS initiatives. Interestingly, during the intervention period, we did not observe a significant decrease in the incidence of BSI due to ESBL-producing Enterobacteriaceae or other MDR GNR organisms, highlighting that in the absence of specific screening for ESBLs, strictly applied IC procedures for CRE are unlikely to blindly decrease other endemic resistance problems.
DECOLONIZATION STRATEGIES FOR MDR GNB
Nearly 30 years of selective decontamination studies that included more than 50 randomized studies and 10 meta-analyses have suggested that, in general, selective oral decontamination (SOD) or selective digestive decontamination [82] . In a large randomized controlled trial performed in The Netherlands, routine use of SDD protocols of colistin, tobramycin and amphotericin B prior to detected colonization with resistant organisms was associated with a 7% increase in the recovery of aminoglycoside-resistant organisms per month [90] . In a retrospective cohort study performed in surgical ICUs in Germany, Lubbert and colleagues [82] reported that gentamicin and colistin SDD achieved decolonization rates of KPC-2 carbapenemase-producing K. pneumoniae in 6/14 patients (43%), but was associated with a rapid increase in secondary bacterial resistance to both antibiotics. Selection of colistin-resistant strains in particular is a major concern because it may predispose patients to infections with pathogens that are untreatable with currently available antibiotics [91] . 14. Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. 
